Anti-angiogenic therapies in the management of glioblastoma
Chinese Clinical Oncology · 2021-08 · 10 (4) · 37-37
DOI: 10.21037/cco.2020.03.06 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Clinical Oncology, 2021-08. Verfasst von Jessica D Schulte und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Glioma, Neovascularization, Pathologic. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of California, San Francisco, CA, USA.
- Department of Neurological Surgery, University of California, San Francisco, CA, USA; Department of Neurology, University of California, San Francisco, CA, USA.
Förderung
- NINDS NIH HHS
Zitieren
APA
Schulte, J. D., Aghi, M. K., & Taylor, J. W. (2021). Anti-angiogenic therapies in the management of glioblastoma. Chinese Clinical Oncology, 10(4), 37-37. https://doi.org/10.21037/cco.2020.03.06
Vancouver
Schulte JD, Aghi MK, Taylor JW. Anti-angiogenic therapies in the management of glioblastoma. Chinese Clinical Oncology. 2021;10(4):37-37. doi:10.21037/cco.2020.03.06
BibTeX
@article{Schulte2021,
author = {Schulte, Jessica D and Aghi, Manish K and Taylor, Jennie W},
title = {Anti-angiogenic therapies in the management of glioblastoma},
journal = {Chinese Clinical Oncology},
year = {2021},
volume = {10},
number = {4},
pages = {37--37},
doi = {10.21037/cco.2020.03.06}
}
EUVIMED